Home

LET’S GO FURTHER...

About

Santhera

We at Santhera are dedicated to developing medicines to meet the needs of patients living with mitochondrial and other rare diseases.

“Mitochondrial Disease Awareness Week 2018 - Raising awareness"


Read more>>
Patients

About Rare Diseases

At Santhera, we are passionate about providing treatment options for patients with rare diseases, specifically in the area of neuro-ophthalmological, neuromuscular und pulmonary conditions – diseases that have a severe impact on the lives of affected children and adults.


Read more>>
Health Care Professionals

Our medicines

Our focus is on the development of treatments for neuro-ophthalmological, neuromuscular and pulmonary diseases that currently lack treatment options. In September 2015, we received our first European Marketing Authorization for Raxone® in the treatment of patients with Leber’s hereditary optic neuropathy.


Read more>>
Investors & Media

Tools and Resources

The Investor and Media center provides information and resources for investor and media communities.


Read more>>
Career

Working @Santhera

Santhera is a dynamic and international employer looking for colleagues who are talented, engaged and committed to growing the organization through the work that they do.


Read more>>

Latest News

Earlier press releases can be found here.
To subscribe to our News Feed, please click here.